Publications by authors named "Gayatri Janardhan"
Article Synopsis
- - Beta thalassemia is a genetic blood disorder leading to inefficient red blood cell production, affecting about 8.5% of people in the UAE and causing significant health and financial issues.
- - Traditional treatment options for β-thalassemia are limited and complicated, prompting research into gene therapy as a possible new and more effective solution.
- - Gene therapy shows promise for permanently curing β-thalassemia, with treatments like FDA-approved ZYNTEGLO offering a potential one-time fix, though the high cost of $2.8 million per patient remains a major barrier.
